SSTR2 and type 2 diabetes mellitus: The effect of the SSTR2 antagonist ZT-01, was assessed under basal conditions of hyperglycemia (T2D animals only) and euglycemia (HFF controls only) in the absence of any manipulations to glucose levels such as those carried out for the OGTT and ITT.